Evaluation of The Use Antituberculosis Drugs and Analysis of Adherence Pulmonary Tuberculosis Patients at The Sidomulyo Health Center, Pekanbaru

  • Denia Pratiwi Prodi Sarjana Farmasi, Fakultas Farmasi dan Ilmu Kesehatan, Universitas Abdurrab
  • Maisarah Maisarah Prodi Sarjana Farmasi, Fakultas Farmasi dan Ilmu Kesehatan, Universitas Abdurrab
  • Deri Islami Prodi Sarjana Farmasi, Fakultas Farmasi dan Ilmu Kesehatan, Universitas Abdurrab

Abstract

Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis. Based on data from the Global Tuberculosis Report in 2022, Indonesia ranks as the second highest TB case after India. This study aims to evaluate the suitability of OAT use in pulmonary tuberculosis patients at the Sidomulyo pekanbaru Health Center from January-December 2022 based on the 2014 Tuberculosis Prevention guidelines by the Ministry of health of the Republic of Indonesia, as well as the relationship between age, duration of treatment,gender, and chronic comorbidities to patient treatment outcomes,and analysis of the level of adherence of pulmonary TB patients. This study is a non-experimental descriptive research with retrospective data retrieval. The results showed that the type of OAT given is OAT type KDT (fixed dose combination) of 99% with a cure rate of 80%. Suitability of indications, dosage and selection of OAT combination has been in accordance with the standards of the National TB guidelines in 2014. Analysis of the relationship between several factors on the results of treatment of patients obtained from the statistical analysis of chi-square test concluded that the age factor (p=0.00001;p<0.05) has a significant relationship while gender (p=0.064;p>0.05), duration of treatment (p=0.860;p>0.05) and chronic comorbidities (p=0.826;p>0.05) had no significant relationship to the patient's treatment outcomes. The level of patient compliance obtained from the results of filling out questionnaires for pulmonary TB patients at the Sidomulyo Health Center has a high compliance of 49%.

Keywords: TBC, Adherence in Tuberculosis Drug, Evaluation of Drug Use

References

Ahdiyah, N. N., Andriani, M., & Andriani, L. (2022). Tingkat Kepatuhan Penggunaan Obat Anti Tuberkulosis Pada Pasien Tb Paru Dewasa Di Puskesmas Putri Ayu. Lumbung Farmasi: Jurnal Ilmu Kefarmasian,3(1),23.Https://Doi.Org/10.31764/Lf.V3i1.6817
Anita, N., & Sari, R. P. (2022). Faktor-Faktor Kesembuhan Penderita Tb Paru Dengan Penyakit Penyerta Diabetes Melitus. Adi Husada Nursing Journal,7(2),51.Https://Doi.Org/10.37036/Ahnj.V7i2.197
Biologi, J., Sains, F., Teknologi, D., Makassar, A., & Mar'iyah, K. (N.D.).Patofisiologi Penyakit Infeksi Tuberkulosis. Http://Journal.Uin-Alauddin.Ac.Id/Index.Php/Psb
Dewi Kristini, T., Hamidah, R., Kesehatan Masyarakat,F.,Muhammadiyah Semarang,U., & Kesehatan Provinsi Jawa Tengah, D. (N.D.). Potensi Penularan Tuberculosis Paru Pada Anggota Keluarga Penderita. In Jurnal Kesehatan Masyarakat Indonesia (Vol. 15, Issue 1).Https://Jurnal.Unimus.Ac.Id/Index.Php/Jkmi,
Fristiohady, A., Ihsan, S., & Haringi, E. (N.D.). Evaluasi Penggunaan Obat Antituberkulosis Pada Pasien Tb Paru Di Rumah Sakit Umum Bahteramas Provinsi Sulawesi Tenggara.1(1).
Ismail,A., Handayany, G. N., & Bakri, M. (N.D.). Evaluasi Penggunaan Obat Antituberkulosis (Oat) Pada Pasien Tuberkulosis Paru Di Puskesmas Jumpandang Baru Makassar.
Kemenkes RI. (2016). Peraturan Menteri Kesehatan Republik Indonesia Nomor 67 Tahun 2016 Tentang Penanggulangan Tuberkulosis. Dinas Kesehatan,163.
Konde, C. P., Asrifuddin, A., & Lang, F. L. F. G. (2020).Hubungan Antara Umur, Status Gizi Dan Kepadatan Hunian Dengan Tuberkulosis Paru Di Puskesmas Tuminting Kota Manado. Jurnal Kesmas,9(1),106-113.
Masrifah, D., & Andarini, Y. D. (2020). Evaluasi Penggunaan Obat Antituberkulosis Pada Pasien Tuberkulosis Rawat Jalan Di Rsud Caruban Periode Januari-Maret 2018. Pharmaceutical Journal Of Islamic Pharmacy,4(1),1-7.Https://Doi.Org/10.21111/Pharmasipha.V4i1.4027
Milantika, J., Akib Yuswar, M., Umilia Purwanti, N., Doktor Haji Hadari Nawawi Kota Pontianak, P., & Korespondensi, P. (2022). Rasionalitas Penggunaan Obat Antituberkulosis Pada Pasien Tuberkulosis Paru Rawat Jalan. Journal Syifa Sciences And Clinical Research (Jsscr), 4.Https://Doi.Org/10.37311/Jsscr.V4i3.15602
Nani Desiyani. (2009). Analisis Faktor-Faktoryangberhubungandengankejadian Kanker Payudara Dirumah Sakitpertamina Cilacap. Jurnal Keperawatan Soedirman, 4(2), 67-73.Http://Www.Jks.Fikes.Unsoed.Ac.Id/Index.Php/Jks/Article/View/224/115
Ningsih, A. S. W., Ramadhan, A. M., & Rahmawati, D. (2022). Kajian Literatur Pengobatan Tuberkulosis Paru Dan Efek Samping Obat Antituberkulosis Di Indonesia. Proceeding Of Mulawarman Pharmaceuticals Conferences,15,231-241.Https://Doi.Org/10.25026/Mpc.V15i1.647
Prananda, M. (N.D.). Evaluasi Penggunaan Obat Anti Tuberkulosis Paru Pada Pasien Dewasa Rawat Jalan Di Unit Pengobatan Penyakit Paru-Paru (Up4)Pontianak.
Qiyaam, N., Furqani, N., Junia Hartanti, D., Program Studi Farmasi, D., Ilmu Kesehatan Universitas Muhammadiyah Mataram, F., Program Studi Farmasi,M., & Ilmu Kesehatan, F. (2020). Evaluasi Penggunaan Obat Antituberkulosis (Oat) Pada Pasien Tuberkulosis Paru Di Puskesmas Kediri Lombok Barat Tahun 2018. Jurnal Ilmu Kefarmasian, 1(1).
Sari, K. E. P., Rizkifani, S., & Iswahyudi. (2021). Evaluasi Penggunaan Obat Anti Tuberkulosis Pada Pasien Baru Tuberkulosis Paru Dewasa Rawat Jalan Di Rs Tk. Ii Kartika Husada Kubu Raya Tahun 2020 Kartini.Jurnal Mahasiswa Farmasi Fakultas Kedokteran Untan,5(1),17.
Sunarmi, S., & Kurniawaty, K. (2022). Hubungan Karakteristik Pasien Tb Paru Dengan Kejadian Tuberkulosis. Jurnal 'Aisyiyah Medika, 7(2), 182-187.Https://Doi.Org/10.36729/Jam.V7i2.865
Tirangga, B., Angin, M. P., & Saputri, G. A. R. (2022). Evaluasi Tingkat Kepatuhan Penggunaan Obat Anti Tuberkulosis (Oat) Terhadap Pasien Tuberkulosis Paru Di Puskesmas Way Jepara Kabupaten Lampung Timur.Jurnal Ilmu Kedokteran Dan Kesehatan, 9(2),837-843.
Published
2024-01-03
How to Cite
Pratiwi, D., Maisarah, M., & Islami, D. (2024). Evaluation of The Use Antituberculosis Drugs and Analysis of Adherence Pulmonary Tuberculosis Patients at The Sidomulyo Health Center, Pekanbaru. Jurnal Ilmu Kesehatan Abdurrab, 1(4), 38-44. Retrieved from https://jurnal.univrab.ac.id/index.php/jika/article/view/4191
Issue
Vol 1 No 4 (2023): Vol 1 No 4 Desember 2023
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Please find the rights and licenses in Jurnal Ilmu Kesehatan Abdurrab. By submitting the article/manuscript of the article, the author(s) accept this policy.

1. License

The non-commercial use of the article will be governed by the Creative Commons Attribution license as currently displayed on Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. 

2. Author’s Warranties

The author warrants that the article is original, written by stated author(s), has not been published before, contains no unlawful statements, does not infringe the rights of others, is subject to copyright that is vested exclusively in the author and free of any third party rights, and that any necessary written permissions to quote from other sources have been obtained by the author(s).

3. User Rights

Jurnal Ilmu Kesehatan Abdurrab spirit is to disseminate articles published are as free as possible. Under the Creative Commons license, Jurnal Ilmu Kesehatan Abdurrab permits users to copy, distribute, display, and perform the work for non-commercial purposes only. Users will also need to attribute authors and Jurnal Ilmu Kesehatan Abdurrab on distributing works in the journal.

4. Rights of Authors

Authors retain all their rights to the published works, such as (but not limited to) the following rights;

  • Copyright and other proprietary rights relating to the article, such as patent rights,
  • The right to use the substance of the article in own future works, including lectures and books,
  • The right to reproduce the article for own purposes,
  • The right to self-archive the article,
  • The right to enter into separate, additional contractual arrangements for the non-exclusive distribution of the article's published version (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal (Jurnal Ilmu Kesehatan Abdurrab).

5. Co-Authorship

If the article was jointly prepared by other authors, any authors submitting the manuscript warrants that he/she has been authorized by all co-authors to be agreed on this copyright and license notice (agreement) on their behalf, and agrees to inform his/her co-authors of the terms of this policy. Jurnal Ilmu Kesehatan Abdurrab will not be held liable for anything that may arise due to the author(s) internal dispute. Jurnal Ilmu Kesehatan Abdurrab will only communicate with the corresponding author.

6. Royalties

This agreement entitles the author to no royalties or other fees. To such extent as legally permissible, the author waives his or her right to collect royalties relative to the article in respect of any use of the article by Jurnal Ilmu Kesehatan Abdurrab.

7. Miscellaneous

Jurnal Ilmu Kesehatan Abdurrab will publish the article (or have it published) in the journal if the article’s editorial process is successfully completed. Jurnal Ilmu Kesehatan Abdurrab's editors may modify the article to a style of punctuation, spelling, capitalization, referencing and usage that deems appropriate. The author acknowledges that the article may be published so that it will be publicly accessible and such access will be free of charge for the readers as mentioned in point 3.

PDF
Abstract views: 230
downloads: 150